Insights

Early multidisciplinary care for chronic kidney disease (CKD) in a clinical pathway (CP) significantly delayed dialysis initiation. This approach also reduced mortality and hospitalization risk for CKD patients.

Area of Science:

  • Nephrology
  • Public Health
  • Healthcare Management

Context:

  • Belgian healthcare authorities introduced a clinical pathway (CP) for chronic kidney disease (CKD) in 2009.
  • Significant costs associated with end-stage kidney disease (ESKD) treatment by dialysis prompted this initiative.
  • A retrospective cohort study was conducted to evaluate the impact of CP on CKD patients.

Purpose:

  • To test the hypothesis that CP enrollment reduces morbidity, mortality, and delays dialysis admission.
  • To analyze the association between CP inclusion and time to dialysis initiation.
  • To assess the impact of CP on mortality and hospitalization risk post-dialysis.

Summary:

  • CKD patients enrolled in a CP (n=25) experienced a significant delay in dialysis initiation compared to controls (n=25).
  • CP inclusion was associated with reduced mortality (HR=0.10) and hospitalization risk (HR=0.30) after starting dialysis.
  • Survival analyses indicated a protective effect of the multidisciplinary CKD-CP.

Impact:

  • Findings suggest that multidisciplinary care within a CKD clinical pathway offers significant benefits.
  • The study highlights the potential for CP to improve patient outcomes and manage healthcare costs.
  • Larger-scale studies are recommended to validate these promising results in a broader population.